Her Highness Sheikha Moza Bint Nasser, Chairman of the Qatar Foundation for Education, Science and Community Development, has opened a wing of blood -forming stem cell transplantation for children in Sidra Medicine, a member of the Qatar Foundation, who is concerned with treating children with blood diseases, immune system disorders and genetic disorders.
Her Highness made an inspection tour through the wing facilities and spoke with the clinical teams working in it, while her highness was briefed on the role played by the stem cell transplant program in developing care and providing stem cell therapy, and providing genetic therapy for children in Qatar and the region.
Her Highness was accompanied during the tour, Minister of Public Health Mansour bin Ibrahim bin Saad Al Mahmoud, members of the Sidra Medical Board of Directors and Dr. Yenbu Cancer CEO, and Professor Ibrahim Janahi, President of the Medical.
This wing is an essential part of the blood -forming cell transplant program in Sidra Medicine, which uses healing treatments to provide care and treatments for the lives of children who develop blood and cancer, including benign and malignant tumors such as leukemia, lymphuma, snowmia, sickle cell anemia, immunodeficiency and metabolic disorders.
The process of transplanting the blood -forming cells is also known as the bone marrow transplant, during which the bone marrow or damaged bone is replaced by healthy stem cells from the patient (self -origin) or from one of the donors (illegal of origin).
An important step
Dr. IPO Tenobo Cartic, CEO of Sidra Medicine, said that the opening of the blood -constituting cell cultivation suite for children, the first of its kind in the country, said an important step in the framework of Sidra Medicine’s efforts to enhance access to health care for children’s lives in Qatar and the region.
She added that in light of the growth witnessed by the blood -forming cell transplant program, the suite will play a vital role in reducing the need for external referrals, and in consolidating Qatar’s position as a pioneering center in providing advanced treatments for children such as cellular therapy and genetic therapy, where Sidra seeks medicine through this to provide sustainable and high -quality care for his patients and their families near their homelands.
For his part, Professor Ibrahim Janahi, the medical president of the medical medicine, said that the opening of a suite for stem cell transplantation in Sidra Medicine confirms the commitment to support the Qatar National Vision 2030, and also establishes the foundations of the knowledge -based economy by building national experiences in accurate and renewed medicine.
He added that Sidra Medical goal is to ensure that every child in Qatar has the best possible treatments near his home and based on clinical excellence.
This new wing, which is managed by the Department of Hematology and Oncology in Sidra Medicine, was designed specifically for patients under the age of 18, while the wing is divided into two main parts, the Department of Children who are subject to blood -forming stem cell transplantation, and the Patient Department with complex diagnoses of blood and tumors, such as cancer, which requires intense chemotherapy and internal care.
The wing, which has 20 beds, is characterized by an initial capacity, with advanced facilities that include high -level insulation facilities that are compatible with international anti -infection standards. The pavilion is scheduled to start receiving patients to perform autonomous transplants in late June, while preparations are underway to provide care for internal patients from children who will undergo agricultural operations from other donors at a later stage.
Advanced care
Dr. Ayman Saleh, Head of the Department of Hematology, Pediatric Oncology, and Stem Cell Services, said that the blood -forming cell transplant program in Sidra Medicine combines major specializations in order to provide advanced and curative care for children who suffer from complicated pathological conditions.
He added that, in light of Sidra’s success in conducting four self -transplantation processes and the current preparations for conducting the transplants of heterosexual cells in the near future, it establishes a solid basis for cellular therapy for children in Qatar, and this service is evidence of the care approach centered around the family and the pioneering treatment that we provide to all our patients. ”
In addition to treating patients with various blood diseases and cancer, the blood -forming cell transplant program in Sidra Medicine is an essential part of the precise medicine strategy aimed at strengthening genetic research programs for autoimmune disorders in children as well as genetic and rare diseases.
The blood -forming cell transplant program supports a qualified team in laboratory work, while the adoption of a good manufacturing practices facility, as it works under the supervision of the advanced cell therapy center.
The Advanced Cellular Treatment Center undertakes the processing and preservation of the blood -forming stem cells, while currently supports Sidra Medicine to become a pioneering center for providing Casgevy, a genetic treatment for both thalassemia and sickle cell anemia.